Uses of Nailon 8% Nail Lacquer
Nailon 8% Nail Lacquer is used for the treatment or prevention of the following disease(s):
Fungal Infections, Dandruff
Side effects of Nailon 8% Nail Lacquer
The most common side effects of Nailon 8% Nail Lacquer are - Itching, Redness, Dryness, Skin Irritation, Burning
These side effects can usually occur in patients. However, these are only indicative and not all patients will experience them.
Precautions while taking Nailon 8% Nail Lacquer
Do not use Nailon 8% Nail Lacquer if you are allergic to - Ciclopirox Topical
If you have heart disease, liver or kidney disease, drug or alcohol addiction, consult your doctor before using Nailon 8% Nail Lacquer.
If you are allergic to any medicine or food, consult your doctor before using this medicine.
Use this medicine under the supervision of your doctor.
To avoid an adverse reaction, consult your doctor if you are already taking other medicines.
Dosage of Nailon 8% Nail Lacquer
Nailon 8% Nail Lacquer contains - Ciclopirox Topical
Ciclopirox appears to modify the plasma membrane of fungi, resulting in the disorganization of internal structures.
Overdose of Nailon 8% Nail Lacquer
The dosage of Nailon 8% Nail Lacquer depends on many factors such as the patient age, health, medical condition or history of the patient and many other conditions.
Please use this medicine as prescribed by your doctor.
Onset of Action of Nailon 8% Nail Lacquer
If you forget to take a dose of Nailon 8% Nail Lacquer, do not take two doses at the same time, there is a risk of overdose.
If you notice any unusual reaction in your body after taking this medicine, contact your doctor immediately or call your local medical emergency number.
Duration of Action of Nailon 8% Nail Lacquer
Precautions & Warnings
Alcohol
Information will be added soon.
Pregnancy
Information will be added soon.
Breastfeeding
Information will be added soon.
Driving
Information will be added soon.
Kidney
Information will be added soon.
Liver
Information will be added soon.
Interactions
Information will be added soon.